Mitral Loop Cerclage Annuloplasty

  • June-Hong KimEmail author


Mitral cerclage annuloplasty, one of the coronary sinus annuloplasty technologies, has the unique feature of having a circumferential tension design to restrain mitral annulus as well as to minimize the possible risk of compressing the nearby left circumflex artery. Mitral loop cerclage is a refined device system designed for mitral cerclage in humans. A first-in-man trial of mitral loop cerclage has shown excellent efficacy in reducing mitral regurgitation and remarkable reverse remodeling of the left ventricle and left atrium, along with the possibility of conversion of atrial fibrillation to sinus rhythm (electrical remodeling).


  1. 1.
    Feldman T, Young A. Percutaneous approaches to valve repair for mitral regurgitation. J Am Coll Cardiol. 2014;63(20):2057–68.CrossRefPubMedGoogle Scholar
  2. 2.
    Siminiak T, Wu JC, Haude M, Hoppe UC, Sadowski J, Lipiecki J, Fajadet J, Shah AM, Feldman T, Kaye DM, Goldberg SL, Levy WC, Solomon SD, Reuter DG. Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN trial. Eur J Heart Fail. 2012;14(8):931–8.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Kim JH, Kocaturk O, Ozturk C, et al. Mitral cerclage annuloplasty, a novel transcatheter treatment for secondary mitral valve regurgitation. Initial results in swine. J Am Coll Cardiol. 2009;54(7):638–51.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Kim JH, Sung SC, Chon MK, Kim JO, Lee SH, Lee SY, Je HG, Choo KS, Hwang JM, Kim JS, Park YH, Chon KJ, Kim CM. Mitral loop cerclage as a variant form of mitral cerclage annuloplasty that adds a device ( CSTV ) for preventing potential complications: a preclinical proof of concept and feasibility study. EuroIntervention. 2016;11:1669–79.CrossRefGoogle Scholar
  5. 5.
    Park YH, Chon MK, Lederman RJ, Sung SC, Je HG, Choo KS, Lee SH, Shin ES, Kim JS, Hwang KW, Lee SY, Chun KJ, Kim CM, Kim JH. Mitral loop cerclage annuloplasty for secondary mitral regurgitation: first human results. JACC Cardiovasc Interv. 2017;10(6):597–610.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.School of Medicine, Pusan National University, Cardiology DepartmentYangsanSouth Korea

Personalised recommendations